Similar articles

• Corticosteroids in ARDS.

  Speich R, Schmid C, Stocker R. Speich R, et al. N Engl J Med. 2006 Jul 20;355(3):317; author reply 318-9. N Engl J Med. 2006. PMID: 16858835 No abstract available.
• Systemic inflammation-associated glucocorticoid resistance and outcome of ARDS.

  Meduri GU, Yates CR. Meduri GU, et al. Ann N Y Acad Sci. 2004 Jun;1024:24-53. doi: 10.1196/annals.1321.004. Ann N Y Acad Sci. 2004. PMID: 15265772 Review.
• [Rational therapeutic regime of glucocorticoid in patients with acute respiratory distress syndrome and its receptor mechanism].

  Ma J. Ma J. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2003 Nov;15(11):680-2. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2003. PMID: 14604487 Review. Chinese.
• Evolution of plasma proinflammatory cytokines in malaria-related ARDS treated with corticosteroids.

  Hiekkanen T, Skogberg K, Pettilä V. Hiekkanen T, et al. Intensive Care Med. 2001 Nov;27(11):1823-4. doi: 10.1007/s00134-001-1116-2. Epub 2001 Oct 12. Intensive Care Med. 2001. PMID: 11810129 No abstract available.
• [Shock lung (ARDS): glucocorticoids?].

  Möllmann HW, Barth J, Schmidt EW, Rohdewald P. Möllmann HW, et al. Anasth Intensivther Notfallmed. 1984 Jun;19(3):99-106. Anasth Intensivther Notfallmed. 1984. PMID: 6383110 Review. German.